Figura N, Cetta F, Angelico M, Montalto G, Cetta D, Pacenti L, Vindigni C, Vaira D, Festuccia F, De Santis A, Rattan G, Giannace R, Campagna S, Gennari C
Institute of Internal Medicine, University of Siena, Italy.
Dig Dis Sci. 1998 Apr;43(4):854-62. doi: 10.1023/a:1018838719590.
Bile may contain a 130-kDa protein endowed with aminopeptidase activity and the ability to promote cholesterol crystallisation. As >90% of H. pylori strains have a similar peptidase activity, and half the isolates express a 110- to 140-kDa antigen, the CagA protein, we investigated a possible association between H. pylori infection and gallstones, and the presence in bile samples of factors related to H. pylori that could increase cholesterol crystallization. The prevalence of H. pylori infection was 82.1% in 112 patients with gallstones and 80.3% in 112 controls (NS). Fifteen bile samples out of 23 specimens from infected patients (65.2%) contained anti-CagA antibodies. A approximately 60-kDa antigen only reacting with an anti-CagA antibody was found in five bile samples (21.7%) from 23 infected patients. One bile sample (4.1%) contained ureA and cagA genes of H. pylori. The homology of CagA with the N-terminal sequence of aminopeptidase N was very low. We concluded that the presence of specific antibody to H. pylori in most bile samples tested and of an H. pylori putative antigen in a discrete number of cases may represent factors that increase the risk of gallstone formation.
胆汁中可能含有一种具有氨肽酶活性且能促进胆固醇结晶的130 kDa蛋白质。由于超过90%的幽门螺杆菌菌株具有相似的肽酶活性,且一半的分离株表达一种110至140 kDa的抗原,即CagA蛋白,我们研究了幽门螺杆菌感染与胆结石之间可能存在的关联,以及胆汁样本中与幽门螺杆菌相关的、可能增加胆固醇结晶的因素。112例胆结石患者中幽门螺杆菌感染率为82.1%,112例对照者中为80.3%(无显著差异)。23例感染患者的样本中有15份胆汁样本(65.2%)含有抗CagA抗体。在23例感染患者的5份胆汁样本(21.7%)中发现了一种仅与抗CagA抗体反应的约60 kDa抗原。1份胆汁样本(4.1%)含有幽门螺杆菌的ureA和cagA基因。CagA与氨肽酶N的N端序列的同源性非常低。我们得出结论,在大多数检测的胆汁样本中存在幽门螺杆菌特异性抗体,以及在少数病例中存在幽门螺杆菌推定抗原,可能是增加胆结石形成风险的因素。